Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden flag Sweden · Delayed Price · Currency is SEK
10.72
+0.02 (0.19%)
Sep 2, 2026, 5:29 PM CET

Vicore Pharma Holding AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,0183,1811,9821,5841,465999
Market Cap Growth
10.32%60.49%25.12%8.13%46.67%-47.51%
Enterprise Value
2,1122,3451,6021,0331,295552
Last Close Price
10.7211.308.4513.8017.4213.54

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-216.88216.88216.88216.88216.88
PS Ratio
755.62833.4418.13---
PB Ratio
3.542.901.763.485.072.61
P/TBV Ratio
3.542.901.763.506.633.16

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-614.4614.65---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----00.00
Net Debt / Equity Ratio
-1.06-1.06-1.02-1.06-0.90-0.97
Net Debt / EBITDA Ratio
-2.586.151.520.921.28
Net Debt / FCF Ratio
1.983.117.011.930.871.40
Asset Turnover
0.000.000.13---
Quick Ratio
12.509.9917.9011.865.695.67
Current Ratio
12.6810.2818.2012.105.815.75
Return on Equity (ROE)
-56.99%-42.92%-21.28%-83.53%-85.79%-80.37%
Return on Assets (ROA)
-34.35%-23.53%-14.05%-47.99%-45.54%-42.76%
Return on Capital Employed (ROCE)
-61.10%-41.30%-16.80%-70.20%-98.60%-76.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.63%-15.01%-8.51%-19.63%-19.69%-29.68%
FCF Yield
-15.13%-11.81%-8.32%-15.75%-20.47%-26.55%
Buyback Yield / Dilution
-32.83%-75.30%-41.72%-33.71%-3.64%-28.44%